We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-14.29%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.5B
AUM Growth
-$3.93B
Cap. Flow
-$718M
Cap. Flow %
-4.36%
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$87M
2
QSR icon
Restaurant Brands International
QSR
+$63.5M
3
BIP icon
Brookfield Infrastructure Partners
BIP
+$62.1M
4
AZN icon
AstraZeneca
AZN
+$55.4M
5
AQN icon
Algonquin Power & Utilities
AQN
+$54.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$159M
2
RY icon
Royal Bank of Canada
RY
+$100M
3
VRN
Veren
VRN
+$89.9M
4
WPM icon
Wheaton Precious Metals
WPM
+$88.9M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$78.3M

Sector Composition

Rank Sector Weight
1 Financials 27.58%
2 Energy 14.56%
3 Industrials 13.17%
4 Technology 10.16%
5 Materials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
826
DELISTED
bluebird bio
BLUE
$393K ﹤0.01%
4,744
+2,125
+81% +$165K
SPOK icon
827
Spok Holdings
SPOK
$230M
$391K ﹤0.01%
62,016
+7,705
+14% +$56.1K
ZTS icon
828
Zoetis
ZTS
$31.3B
$386K ﹤0.01%
2,243
-8,713
-80% -$1.51M
KDP icon
829
Keurig Dr Pepper
KDP
$42.3B
$383K ﹤0.01%
10,825
-54,471
-83% -$1.98M
JNCE
830
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$382K ﹤0.01%
126,073
-45,051
-26% -$219K
VLGEA icon
831
Village Super Market
VLGEA
$638M
$381K ﹤0.01%
16,713
+5,778
+53% +$136K
CTMX icon
832
CytomX Therapeutics
CTMX
$730M
$379K ﹤0.01%
207,071
+6,872
+3% +$13.2K
RVLV icon
833
Revolve Group
RVLV
$1.72B
$377K ﹤0.01%
+14,554
New +$537K
LGF.B
834
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$363K ﹤0.01%
41,145
-56,877
-58% -$648K
CCS icon
835
Century Communities
CCS
$2.04B
$362K ﹤0.01%
+8,051
New +$407K
CIA icon
836
Citizens
CIA
$198M
$360K ﹤0.01%
+85,939
New +$310K
ACH
837
Accendra Health
ACH
$84.6M
$359K ﹤0.01%
+11,421
New +$414K
PFG icon
838
Principal Financial Group
PFG
$24.6B
$358K ﹤0.01%
+5,355
New +$377K
FIZZ icon
839
National Beverage
FIZZ
$2.93B
$355K ﹤0.01%
+7,251
New +$338K
AGS
840
DELISTED
PlayAGS
AGS
$351K ﹤0.01%
68,003
+6,310
+10% +$36.7K
CHRS icon
841
Coherus Oncology
CHRS
$176M
$350K ﹤0.01%
48,389
-15,402
-24% -$134K
CMRX
842
DELISTED
Chimerix, Inc.
CMRX
$349K ﹤0.01%
167,877
-59,587
-26% -$191K
YUM icon
843
Yum! Brands
YUM
$41.2B
$347K ﹤0.01%
+3,057
New +$355K
PNFP icon
844
Pinnacle Financial Partners Inc
PNFP
$16.2B
$339K ﹤0.01%
+4,695
New +$370K
CMCM
845
Cheetah Mobile
CMCM
$94.7M
$337K ﹤0.01%
97,685
-375
-0.4% -$1.51K
CTT
846
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$337K ﹤0.01%
33,469
-10,186
-23% -$93.3K
CUBI icon
847
Customers Bancorp
CUBI
$2.82B
$332K ﹤0.01%
9,787
-1,710
-15% -$69.5K
HSTM icon
848
HealthStream
HSTM
$849M
$331K ﹤0.01%
+15,250
New +$304K
CLF icon
849
Cleveland-Cliffs
CLF
$6.93B
$328K ﹤0.01%
+21,328
New +$510K
CHRW icon
850
C.H. Robinson
CHRW
$17.5B
$324K ﹤0.01%
+3,198
New +$334K
32 33
34
35 36

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2022 Portfolio in Review

As of Q2 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,265 positions worth $16.5B, down 19% from $20.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $718M in Q2 2022, closing 243 positions and reducing 360 holdings. Its most notable exit was Alibaba, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in GSK worth $49.3M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2022 buy was GSK: 905,598 shares worth $49.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q2 2022, an estimated $87M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2022 reduction was Apple, cutting an estimated $159M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Alibaba in Q2 2022, selling an estimated $44.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 33% of its $16.5B portfolio in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 250 new positions and closed 243 in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 19% quarter-over-quarter to $16.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2022, filed 5 Aug 2022.